Clinical trial Recruiting at 13 sites Observational Ages 45 and up

Comparing two rod techniques for spinal fusion surgery

Official title: Durability of Supplementary Rod Constructs-SuppleMentAry Rod Technique (SMART)-for Long-segment Posterior Instrumented Spinal Fusion Procedures: A Multicenter Retrospective Comparative Study With Dual-rod Constructs

Run by AO Foundation, AO Spine · NCT06368245 · Data updated 2026-11-12

This study is testing whether using a different type of rod in spinal fusion surgery can help prevent problems after the operation for people who have had back surgery.

Quick facts

Study typeObservational
Ages45 Years and up
SexAll
Enrollment1244 (estimated)
SponsorAO Foundation, AO Spine
Academic / other
Drugs / interventionsradiation
Locations17 sites (Redwood City, California and 16 other locations)
StatusRecruiting
StartedMarch 24, 2025
Main results expectedDecember 15, 2027
Study endsJuly 31, 2029
Registry record updatedOctober 1, 2026
Trial IDNCT06368245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 45 years and older who have received long-segment posterior thoracolumbar instrumented fusion using either supplementary or dual-rod constructs.

Probably not a fit

Patients who have not undergone long-segment posterior thoracolumbar instrumented fusion or are younger than 45 years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter retrospective comparative cohort study evaluates the outcomes of long-segment posterior thoracolumbar instrumented fusion surgeries using either supplementary rod constructs or dual-rod constructs. It aims to enroll 1244 patients who have undergone either primary or revision surgeries, analyzing their medical records to assess the effectiveness of the supplementary rod constructs in reducing risks of mechanical complications. The study will provide long-term clinical evidence on the benefits of these constructs in spinal fusion procedures.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing spinal fusion.

How similar studies have gone: While this study is exploring a specific comparative approach, similar studies have shown promise in evaluating different surgical techniques in spinal fusion.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 45 years and older.
* Patients receiving long-segment posterior TL instrumented fusion using either supplementary rod constructs or dual-rod constructs (the index surgery).

  * Long-segment is defined as the UIV at a thoracic level and the LIV at the sacrum/ilium.
  * Supplementary rod constructs are defined as: in addition to the traditional two primary rods, at least one supplementary rod (eg, accessory rods or satellite rods) is used, and at least one supplementary rod and one primary rod (ie, at least two rods) together must span multiple (≥ 2) vertebral levels. The supplementary rod constructs do not include rods connected end-to-end or side-to-side that do not bridge multiple vertebral levels.
  * The index surgery can be a primary surgery or a revision surgery.
  * The index surgery, staged or non-staged, must use posterior spinal fusion but can be in combination with other approaches such as an anterior procedure.
* If the index surgery is a revision surgery, the primary rods must be replaced in the revision surgery, with the exception of Harrington or Luque rods which can remain in place.

  o If the Harrington or Luque rods remain in situ, they must already have the UIV at the thoracic level and the LIV at the sacrum/ilium, or an extension of the existing Harrington or Luque is performed such that the UIV is at the thoracic level and the LIV at the sacrum/ilium.
* The index surgery was performed between January 1, 2014, and December 31, 2020, inclusive.
* Minimum 3 months of FU after the index surgery.
* Ability to provide informed consent according to the IRB/EC defined and approved procedures if applicable for retrospective data analysis.

Exclusion Criteria:

* Spinal fusion performed for acute trauma (ie, ≤ 1 year of trauma).
* Spinal fusion performed for tumor.
* Spinal fusion performed for infection.
* Patients with Parkinson's Disease.
* Patients with neuromuscular disorders.
* Patients with spine malignancies requiring chemo- or radiation therapy.

Where it's running

  • Stanford Spine Clinic
    Redwood City, California, United States
    Recruiting
  • University of California
    Sacramento, California, United States
    Recruiting
  • John Hopkis Hospital
    Baltimore, Maryland, United States
    Recruiting
  • University of Minnesota Medical Center
    Minneapolis, Minnesota, United States
    Recruiting
  • Washington University in St. Louis, School of Medicine
    St Louis, Missouri, United States
    Recruiting
  • Columbia University / NYP Och Spine Hospital
    New York, New York, United States
    Recruiting
Show 11 more locations
  • University of Virginia
    Charlottesville, Virginia, United States
    Recruiting
  • University of Calgary Spine
    Calgary, Canada
    Recruiting
  • University of Toronto
    Toronto, Canada
    Recruiting
  • Kothari Medical Centre
    Kolkata, India
    Recruiting
  • University of Tokyo
    Tokyo, Japan
    Recruiting
  • Hospital Vall d´Hebron
    Barcelona, Spain
    Recruiting
  • Acibadem Maslak Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting
  • UCSF Spine Center
    San Francisco, California, United States
    Terminated
  • Washington University in St. Louis, School of Medicine, Saint Louis, Missouri 63110
    St Louis, Missouri, United States
    Completed
  • Duchess of Kent Children's Hospital
    Hong Kong, China
    Completed
  • Hamamatsu University School of Medicine
    Hamamatsu, Japan
    Completed

Study contacts

  • Principal investigator: Justin S Smith, MD, PhD — Professor of Neurosurgery Chief of Spine Division, Fellowship Director University of Virginia
  • Study coordinator: Alix Frischknecht
  • Email: alix.frischknecht@aofoundation.org
  • Phone: +41 79 606 41 48

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.